Published ahead of print on May 12, 2005, doi:10.1165/rcmb.2004-0330OC
American Journal of Respiratory Cell and Molecular Biology. Vol. 33, pp. 145-152, 2005
© 2005 American Thoracic Society DOI: 10.1165/rcmb.2004-0330OC
Bone MarrowDerived Mesenchymal Stem Cells in Repair of the Injured Lung
Mauricio Rojas,
Jianguo Xu,
Charles R. Woods,
Ana L. Mora,
Willy Spears,
Jesse Roman and
Kenneth L. Brigham
Division of Pulmonary, Allergy and Critical Care Medicine; Center for Translational Research of the Lung, McKelvey Center for Lung Transplantation, Department of Medicine, Emory University School of Medicine; and Atlanta Veterans Affairs Medical Center, Atlanta, Georgia
Correspondence and requests for reprints should be addressed to Mauricio Rojas, Division of Pulmonary, Allergy and Critical Care Medicine, Center for Translational Research of the Lung, Emory University School of Medicine, Atlanta, GA 30322. E-mail: mrojas{at}emory.edu
We sought to determine whether an intact bone marrow is essential to lung repair following bleomycin-induced lung injury in mice, and the mechanisms of any protective effects conferred by bone marrowderived mesenchymal stem cell (BMDMSC) transfer. We found that myelosupression increased susceptibility to bleomycin injury and that BMDMSC transfer was protective. Protection was associated with the differentiation of engrafted BMDMSC into specific and distinct lung cell phenotypes, with an increase in circulating levels of G-CSF and GM-CSF (known for their ability to promote the mobilization of endogenous stem cells) and with a decrease in inflammatory cytokines. In vitro, cells from injured, but not from normal, mouse lung produced soluble factors that caused BMDMSC to proliferate and migrate toward the injured lung. We conclude that bone marrow stem cells are important in the repair of bleomycin-injured lung and that transfer of mesenchymal stem cells protects against the injury. BMDMSC localize to the injured lung and assume lung cell phenotypes, but protection from injury and fibrosis also involves suppression of inflammation and triggering production of reparative growth factors.
Key Words: stem cells lung injury bleomycin
This article has been cited by other articles:

|
 |

|
 |
 
S. H. Abman and M. A. Matthay
Mesenchymal Stem Cells for the Prevention of Bronchopulmonary Dysplasia: Delivering the Secretome
Am. J. Respir. Crit. Care Med.,
December 1, 2009;
180(11):
1039 - 1041.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. van Haaften, R. Byrne, S. Bonnet, G. Y. Rochefort, J. Akabutu, M. Bouchentouf, G. J. Rey-Parra, J. Galipeau, A. Haromy, F. Eaton, et al.
Airway Delivery of Mesenchymal Stem Cells Prevents Arrested Alveolar Growth in Neonatal Lung Injury in Rats
Am. J. Respir. Crit. Care Med.,
December 1, 2009;
180(11):
1131 - 1142.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Aslam, R. Baveja, O. D. Liang, A. Fernandez-Gonzalez, C. Lee, S. A. Mitsialis, and S. Kourembanas
Bone Marrow Stromal Cells Attenuate Lung Injury in a Murine Model of Neonatal Chronic Lung Disease
Am. J. Respir. Crit. Care Med.,
December 1, 2009;
180(11):
1122 - 1130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. D. Salazar, S. M. Lankford, and A. R. Brody
Mesenchymal stem cells produce Wnt isoforms and TGF-{beta}1 that mediate proliferation and procollagen expression by lung fibroblasts
Am J Physiol Lung Cell Mol Physiol,
November 1, 2009;
297(5):
L1002 - L1011.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. Lee, X. Fang, N. Gupta, V. Serikov, and M. A. Matthay
Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung
PNAS,
September 22, 2009;
106(38):
16357 - 16362.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kumamoto, T. Nishiwaki, N. Matsuo, H. Kimura, and K. Matsushima
Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury
Eur. Respir. J.,
September 1, 2009;
34(3):
740 - 748.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. D. Hardie, S. W. Glasser, and J. S. Hagood
Emerging Concepts in the Pathogenesis of Lung Fibrosis
Am. J. Pathol.,
July 1, 2009;
175(1):
3 - 16.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Germano, P. Blyszczuk, A. Valaperti, G. Kania, S. Dirnhofer, U. Landmesser, T. F. Luscher, L. Hunziker, H. Zulewski, and U. Eriksson
Prominin-1/CD133+ Lung Epithelial Progenitors Protect from Bleomycin-induced Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
May 15, 2009;
179(10):
939 - 949.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Fritzell Jr., Q. Mao, S. Gundavarapu, T. Pasquariello, J. M. Aliotta, A. Ayala, J. F. Padbury, and M. E. De Paepe
Fate and Effects of Adult Bone Marrow Cells in Lungs of Normoxic and Hyperoxic Newborn Mice
Am. J. Respir. Cell Mol. Biol.,
May 1, 2009;
40(5):
575 - 587.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Hongling Du and H. S. Taylor
Reviews: Stem Cells and Female Reproduction
Reproductive Sciences,
February 1, 2009;
16(2):
126 - 139.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Iyer, A. M. Ramirez, J. D. Ritzenthaler, E. Torres-Gonzalez, S. Roser-Page, A. L. Mora, K. L. Brigham, D. P. Jones, J. Roman, and M. Rojas
Oxidation of extracellular cysteine/cystine redox state in bleomycin-induced lung fibrosis
Am J Physiol Lung Cell Mol Physiol,
January 1, 2009;
296(1):
L37 - L45.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Matute-Bello, C. W. Frevert, and T. R. Martin
Animal models of acute lung injury
Am J Physiol Lung Cell Mol Physiol,
September 1, 2008;
295(3):
L379 - L399.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Summer and A. Fine
Mesenchymal Progenitor Cell Research: Limitations and Recommendations
Proceedings of the ATS,
August 15, 2008;
5(6):
707 - 710.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Loebinger, E. K. Sage, and S. M. Janes
Mesenchymal Stem Cells as Vectors for Lung Disease
Proceedings of the ATS,
August 15, 2008;
5(6):
711 - 716.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Krause
Bone Marrow-derived Cells and Stem Cells in Lung Repair
Proceedings of the ATS,
April 15, 2008;
5(3):
323 - 327.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Serrano-Mollar, M. Nacher, G. Gay-Jordi, D. Closa, A. Xaubet, and O. Bulbena
Intratracheal Transplantation of Alveolar Type II Cells Reverses Bleomycin-induced Lung Fibrosis
Am. J. Respir. Crit. Care Med.,
December 15, 2007;
176(12):
1261 - 1268.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Xu, A. Mora, H. Shim, A. Stecenko, K. L. Brigham, and M. Rojas
Role of the SDF-1/CXCR4 Axis in the Pathogenesis of Lung Injury and Fibrosis
Am. J. Respir. Cell Mol. Biol.,
September 1, 2007;
37(3):
291 - 299.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Wong, A. E. Dutly, A. Sacher, H. Lee, D. M. Hwang, M. Liu, S. Keshavjee, J. Hu, and T. K. Waddell
Targeted cell replacement with bone marrow cells for airway epithelial regeneration
Am J Physiol Lung Cell Mol Physiol,
September 1, 2007;
293(3):
L740 - L752.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Gupta, X. Su, B. Popov, J. W. Lee, V. Serikov, and M. A. Matthay
Intrapulmonary Delivery of Bone Marrow-Derived Mesenchymal Stem Cells Improves Survival and Attenuates Endotoxin-Induced Acute Lung Injury in Mice
J. Immunol.,
August 1, 2007;
179(3):
1855 - 1863.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Xu, C. R. Woods, A. L. Mora, R. Joodi, K. L. Brigham, S. Iyer, and M. Rojas
Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice
Am J Physiol Lung Cell Mol Physiol,
July 1, 2007;
293(1):
L131 - L141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. T. Hennrick, A. G. Keeton, S. Nanua, T. G. Kijek, A. M. Goldsmith, U. S. Sajjan, J. K. Bentley, V. N. Lama, B. B. Moore, R. E. Schumacher, et al.
Lung Cells from Neonates Show a Mesenchymal Stem Cell Phenotype
Am. J. Respir. Crit. Care Med.,
June 1, 2007;
175(11):
1158 - 1164.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Garg, M. Rojas, A. Ravi, K. Bockbrader, S. Epstein, M. Vijay-Kumar, A. T. Gewirtz, D. Merlin, and S. V. Sitaraman
Selective Ablation of Matrix Metalloproteinase-2 Exacerbates Experimental Colitis: Contrasting Role of Gelatinases in the Pathogenesis of Colitis
J. Immunol.,
September 15, 2006;
177(6):
4103 - 4112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. L. Rawlins and B. L. M. Hogan
Epithelial stem cells of the lung: privileged few or opportunities for many?
Development,
July 1, 2006;
133(13):
2455 - 2465.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Martinez and M. P. Keane
Update in diffuse parenchymal lung diseases 2005.
Am. J. Respir. Crit. Care Med.,
May 15, 2006;
173(10):
1066 - 1071.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Weiss, M. A. Berberich, Z. Borok, D. B. Gail, J. K. Kolls, C. Penland, and D. J. Prockop
Adult Stem Cells, Lung Biology, and Lung Disease
Proceedings of the ATS,
May 1, 2006;
3(3):
193 - 207.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Denburg and S. F. van Eeden
Bone marrow progenitors in inflammation and repair: new vistas in respiratory biology and pathophysiology.
Eur. Respir. J.,
March 1, 2006;
27(3):
441 - 445.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. N. Lama and S. H. Phan
The extrapulmonary origin of fibroblasts: stem/progenitor cells and beyond.
Proceedings of the ATS,
January 1, 2006;
3(4):
373 - 376.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 American Thoracic Society.
|
|
|